Stephen R. Auten

Taft Stettinius & Hollister LLP

Stephen R. Auten is head of Taft’s Pharmaceutical & Life Sciences Litigation practice area. He is a widely recognized and seasoned attorney in Hatch-Waxman and biosimilar matters, including related patent litigation, and is followed by key industry leaders, law firms, analysts, educators and others on his LinkedIn blog “Hatch Waxman ANDA Litigation Forum” or HALF, which has over 8,600 members worldwide.

He currently represents clients primarily in the areas of Paragraph IV design strategies, Hatch-Waxman litigation, and biosimilar market opportunities. Steve is a member of Taft’s Executive Committee.

A frequent author, Steve was an associate editor for Pre-ANDA Litigation: Strategies & Tactics for Developing a Drug Product and Patent Portfolio, a leading reference book published by the American Bar Association.

The second edition will be published in early 2018.  He also served as an associate editor and chapter author for the second edition of ANDA Litigation: Strategies & Tactics for Pharmaceutical Patent Litigators, which is a must-have for drug patent litigators. His chapter, concerning declaratory judgment jurisdiction, was cited by Judge Andrews in a recent opinion.

Prior to joining Taft, Steve was already well-known in the intellectual property community due to his long leadership run at Sandoz Inc., the generic drug division of Novartis and one of the largest in the world.

At Sandoz, Steve figured prominently in seminal decisions by the Court of Appeals for the Federal Circuit and the Supreme Court concerning small molecule/patent law litigation. Steve was on the executive team and a critical contributor to the growth and long-term business strategy of the company.

His final role was as Vice-President, Head of Intellectual Property for North America.  Under Steve’s leadership, Sandoz was recognized as having “second best track record for court outcomes” among all generic drug companies (RBC’s Industry Comment, Jan. 15, 2010, at p. 4).

Further, in a decision believed to be the only of its kind, Steve led the charge in successfully persuading FDA to overturn its grant of New Chemical Entity exclusivity for TORISEL (temsirolimus) injection, thus allowing for generic entry many years before previously estimated.

Cost

Rate : $$$

What types of cases Attorney Stephen R. Auten & Taft Stettinius & Hollister LLP can handle?
Taft Stettinius & Hollister LLP can handle cases related to laws concerning Copyright Application, Personal Injury, Health Care, Intellectual Property, Product Liability. We manually verify each attorney’s practice areas before approving their profiles and reviews on our website.
Where is Taft Stettinius & Hollister LLP located?
Taft Stettinius & Hollister LLP is located at 111 E Upper Wacker Dr #2800, Chicago, IL 60601, USA. You can reach out to Taft Stettinius & Hollister LLP using their phone line (312) 840-4313. You can also check their website taftlaw.com.
How much would it cost to hire Taft Stettinius & Hollister LLP?
Stephen R. Auten lawyer charges are specific to each case. However, they work with contingency fees and its ranges from $$ to $$$. They also provide free consultation [and no obligation quotes] if you are interested to hire.
Are Stephen R. Auten reviews trust-able?
We have the ratings and reviews moderation team who checks and verifies every review submitted on our website manually. You can trust all the reviews you see on Stephen R. Auten lawyer profile listing.

Rate and write a review

Your email address will not be published. Required fields are marked *

Is this your profile?Claim it now.

Make sure your information is up to date.
Taft Stettinius & Hollister LLP
East Upper Wacker Drive 111
Chicago 60601 IL US
Get directions

Brian Orlow

0.0
Main Street 71-18
11367 NY US
Advertisement

Lina Stillman

5.0
Broadway 42
New York 10006 NY US
Advertisement